Osborne Clarke - UK’s Post

AI has the potential to transform healthcare, and governments worldwide are talking up AI as a powerful factor in confronting the difficulties faced by a confluence of issues: the rising cost of healthcare, ageing populations and the challenges associated with increasingly complex treatments of chronic conditions. The MHRA's AI strategy may have come at an exciting time for the life sciences industry but this is also tempered by regulatory uncertainty. How far will the MHRA go to fill gaps in the regulatory regime? Our Insight unpacks the MHRA's regulatory approach to AI > https://lnkd.in/e7SJ-7UR Connect with our experts < Peter Rudd-Clarke, Tamara Quinn and Anna L. #ArtificialIntelligience #DigitalHealth #UKHealthcare #NHS

  • No alternative text description for this image
Katie Vickery

International Regulatory and Compliance Partner at Osborne Clarke

3w

Such an important topic! Thank you.

Like
Reply

To view or add a comment, sign in

Explore topics